Avian Flu Vaccine Study

Now Enrolling in Baton Rouge, Norfolk, Grand Island and Sioux City

Now Enrolling

About this research study

Avian influenza is an infectious disease that can infect both humans and birds. The possibility of the virus crossing from birds to infect humans could create the opportunity for a potential pandemic. Research studies are crucial, especially for developing vaccines to protect children, seniors, and people with underlying medical conditions.

Velocity is conducting a research study on an investigational avian flu vaccine for generally healthy adults.

Eligible participants...

  • Must be age 65 or older
  • Must NOT be pregnant, lactating, or intending to become pregnant.
  • Must NOT have received the H5 influenza vaccine, or have a known history of H5 influenza infection
  • Must NOT have received any vaccinations (other than COVID-19 vaccines) within 14 days (inactivated vaccines) or 28 days (live vaccines)
  • May receive compensation for study-related time
  • Do not need insurance to join this study

For more information, complete the form on this page. After you submit your information, a Velocity enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.

Enter your info

Study Locations

Baton Rouge, Louisiana • Velocity Clinical Research

7912 Summa Ave, Baton Rouge, LA 70809
Phone: (225) 900-7739

Norfolk, Nebraska • Velocity Clinical Research

3400 W Norfolk Avenue, Norfolk, NE 68701
Phone: (402) 371-0797

Grand Island, Nebraska • Velocity Clinical Research

3537 West 13th St., Ste. 100, Grand Island, NE 68803
Phone: (308) 365-8900

Sioux City, Iowa • Velocity Clinical Research

4802 Sunnybrook Drive, Sioux City, IA 51106
Phone: (712) 639-6300

©2023 Velocity Clinical Research | All Rights Reserved | Privacy Policy